White label ELPA - ClinicalTrials.eu

Study of EO2463, Lenalidomide, and Rituximab for Patients with Indolent Non-Hodgkin’s Lymphoma

Recruiting

2 1 1 1
Investigated diseases:
- Non-Hodgkin’s lymphoma
Investigated drugs:
- Omp64
- Omp65
- Omp66
Study Comparing Buckberg and Del Nido Solutions for Heart Surgery in Patients with Cardiovascular Disease

Recruiting

3 1 1 1
Investigated diseases:
- Cardiovascular disorder
Investigated drugs:
Study on Clopidogrel’s Effect in Preventing Systemic Sclerosis for Patients with Raynaud’s Phenomenon and Specific Immune Conditions

Recruiting

4 1 1
Investigated diseases:
- Raynaud’s phenomenon
Investigated drugs:
- Clopidogrel
Study on Progesterone to Prevent Preterm Birth in Pregnant Women with Placenta Previa

Recruiting

3 1 1 1
Investigated diseases:
- Placenta praevia
Investigated drugs:
- Progesterone
Study of Iberdomide and Isatuximab for Maintenance Therapy in Patients with Newly Diagnosed Multiple Myeloma After Stem-Cell Transplantation

Recruiting

3 1 1 1
Investigated diseases:
- Plasma cell myeloma
Investigated drugs:
Study on the Safety and Effects of HMB-001 for Patients with Glanzmann Thrombasthenia

Recruiting

2 1 1
Investigated diseases:
- Glanzmann’s disease
Investigated drugs:
- Hmb-001
Study on Fluconazole and Sodium Chloride to Prevent Fungal Infections in Patients Undergoing Cystectomy

Recruiting

3 1 1
Investigated diseases:
- Fungal infection
Investigated drugs:
- Fluconazole
- Sodium Chloride
Study on Sotorasib for Patients with Advanced KRAS G12C-Mutated Non-Small Cell Lung Cancer and Comorbidities

Recruiting

2 1 1 1
Investigated diseases:
Investigated drugs:
- Sotorasib
Study on Abdominal Aortic Aneurysm Treatment with Allogeneic Adipose-Derived Mesenchymal Stem Cells for Patients Undergoing Endovascular Repair

Recruiting

2 1 1
Investigated diseases:
- Aortic aneurysm
Investigated drugs:
- Allogeneic Adipose-Derived Mesenchymal Stem Cells Expanded
Study on Niraparib with Immunotherapy for Patients with SLFN11-Positive Extensive-Stage Small Cell Lung Cancer

Recruiting

2 1 1 1
Investigated diseases:
Investigated drugs:

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies